USPTO serial 97516473
SYNEXUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 1, 2024
- Examiner
- KEENAN, CAYLA FAY
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with SYNEXUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Synexus Clinical Research US, Inc.
Wilmington, NC
Other trademarks owned by Synexus Clinical Research US, Inc.
Synexus Clinical Research US, Inc.
Wilmington, NC
Other trademarks owned by Synexus Clinical Research US, Inc.
Synexus Clinical Research US, Inc.
Wilmington, NC
Other trademarks owned by Synexus Clinical Research US, Inc.
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kenya Williams
Kenya Williams THERMO FISHER SCIENTIFIC5823 NEWTON DRIVECARLSBAD, CA 92008United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Recruitment and selection services relating to clinical trials, namely, posting of clinical trial notices for the purpose of recruiting patients for participation in clinical trials for the testing of drugs; business management services in the field of clinical trials, namely, providing information management services; providing marketing services for the medical and pharmaceutical products of others; Collection and compilation of market research information for clinical trials; business information, advisory and consultancy services relating to clinical trials | ACTIVE | Dec 31, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Synexus Clinical Research US, Inc.
- Other trademarks owned by Synexus Clinical Research US, Inc.
- Other trademarks owned by Synexus Clinical Research US, Inc.
- Other trademarks in Class 035
- Similar marks named SYNEXUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Oct 1, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 29, 2024 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Aug 29, 2024 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 1, 2024 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jul 31, 2024 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jun 12, 2024 | IUAF | USE AMENDMENT FILED | — |
| Jun 12, 2024 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Jun 12, 2024 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 12, 2024 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Jun 12, 2024 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 12, 2024 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Dec 12, 2023 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Oct 17, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 17, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 27, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 8, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 8, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Sep 8, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Sep 8, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 16, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 16, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 16, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 11, 2023 | XELG | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | — |
| Aug 11, 2023 | XELR | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | — |
| May 11, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 9, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 15, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 27, 2022 | NWAP | NEW APPLICATION ENTERED | — |